Three-dimensional quantitative structure-activity relationship of 1,4-dihydropyridines as antitubercular agents

Journal of Medicinal Chemistry

Volumn 45, Issue 22, 2002, Pages 4858-4867

  Eharkar, Prashant S ^a   Desai, Bhavik ^b   Gaveria, Harsukh ^b   Varu, Bharat ^b   Loriya, Rajesh ^b   Naliapara, Yogesh ^b   Shah, Anamik ^b   Kulkarni, Vithal M ^a  

^a UNIVERSITY OF MUMBAI   (India)

^b SAURASHTRA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDROPYRIDINE; DIHYDROPYRIDINE DERIVATIVE; TUBERCULOSTATIC AGENT;

ARTICLE; ATOM; DRUG ACTIVITY; DRUG CONFORMATION; EVALUATION; METHODOLOGY; MODEL; MOLECULAR MODEL; MOLECULE; MYCOBACTERIUM TUBERCULOSIS; PHYSICAL CHEMISTRY; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STEREOCHEMISTRY; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING;

ANTITUBERCULAR AGENTS; DIHYDROPYRIDINES; MODELS, MOLECULAR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037168055     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm020217z     Document Type: Article

References (38)

1. Nakajima, H. Tuberculosis: A Global Emergency. World Health 1993, 46, 3.
2. Dolin, P. J.; Raviglione, M. D.; Kochi, A. Global Tuberculosis Incidence and Mortality during 1990-2000. Bull. WHO 1994, 72, 213-220.
3. Rouchi, A. M. Tuberculosis: A Tough Adversary. Chem. Eng. News 1999, 77, 52-69.
4. Nunn, P.; Kochi, A. A Deadly Duo - TB and AIDS. World Health 1999, 46, 7-8.
5. Raviglione, M. D.; Snider, D. E., Jr.; Kochi, A. Global Epidemiology of Tuberculosis: Morbidity and Mortality of a Worldwide Epidemic. JAMA 1995, 273, 220-226.
6. Johnsson, K.; Schultz, P. G. Mechanistic Studies of the Oxidation of Isoniazid by Catalase Peroxidase from Mycobacterium tuberculosis. J. Am. Chem. Soc. 1994, 116, 7425-7426.
7. Wächter, G. A.; Davis, M. C.; Martin, A. R.; Franzblau, S. G. Antimycobacterial Activity of Substituted Isosteres of Pyridine- and Pyrazinecarboxylic Acids. J. Med. Chem. 1998, 41, 2436-2438.
8. Desai, B.; Sureja, D.; Naliapara, Y.; Shah, A.; Saxena, A. Synthesis and QSAR Studies of 4-Substituted phenyl-2,6-dimethyl-3,5-bis-N-(substituted phenyl)-carbamoyl-1,4-dihydropyridines as Potential Antitubercular Agents. Bioorg. Med. Chem. 2001, 4, 1993-1997.
9. Cramer, R. D., III.; Patterson, D. E.; Bunce, J. D. Comparative Molecular Field Analysis (CoMFA). 1. Effect of Shape on Binding of Steroids to Carrier Proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
10. Kulkarni, S. S.; Kulkarni, V. M. Three-Dimensional Quantitative Structure-Activity Relationship of Interleukin 1-β Converting Enzyme Inhibitors: A Comparative Molecular Field Analysis Study. J. Med. Chem. 1999, 42, 373-380.
11. Gokhale, V. M.; Kulkarni, V. M. Comparative Molecular Field Analysis of Fungal Squalene Epoxidase Inhibitors. J. Med. Chem. 1999, 42, 5348-5358.
12. Makhija, M. T.; Kulkarni, V. M. Molecular Electrostatic Potentials as Input for the Alignment of HIV-1 Integrase Inhibitors in 3D QSAR. J. Comput.-Aided Mol. Des. 2001, 15, 961-978.
13. Talele, T. T.; Kulkarni, S. S.; Kulkarni, V. M. Development of Pharmacophore Alignment Models as Input for Comparative Molecular Field Analysis of a Diverse Set of Azole Antifungal Agents. J. Chem. Inf. Comput. Sci. 1999, 39, 958-966.
14. Klebe, G.; Abraham, U.; Mietzner, T. Molecular Similarity Indices in a Comparative Analysis (CoMSIA) of Drug Molecules to Correlate and Predict Their Biological Activity. J. Med. Chem. 1994, 37, 4130-4146.
15. Bohm, M.; Sturzebecher, J.; Klebe, G. Three-Dimensional Quantitative Structure-Activity Relationship Analyses using Comparative Molecular Field Analysis and Comparative Molecular Similarity Indices Analysis to Elucidate Selectivity Differences of Inhibitors Binding to Trypsin, Thrombin, and Factor Xa. J. Med. Chem. 1999, 42, 458-477.
16. Klebe, G. Comparative Molecular Similarity Indices Analysis: CoMSIA. Perspect. Drug Discovery Des. 1998, 12, 87-104.
17. Rogers, D.; Hopfinger, A. J. Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure - Property Relationships. J. Chem. Inf. Comput. Sci. 1994, 34, 854-866.
18. Shi, L. M.; Fan, Y.; Myers, T. G.; O'Connor, P. M.; Paull, K. D.; Friend, S. H.; Weinstein, J. N. Mining the NCI Anticancer Drug Discovery Databases: Genetic Function Approximation for the QSAR Study of Anticancer Ellipticine Analogues. J. Chem. Inf. Comput. Sci. 1998, 38, 189-199.
19. Venkatarangan, P.; Hopfinger, A. J. Prediction of Ligand-Receptor Binding Thermodynamics by Free Energy Force Field Three-Dimensional Quantitative Structure-Activity Relationship Analysis: Applications to a Set of Glucose Analogue Inhibitors of Glycogen Phosphorylase. J. Med. Chem. 1999, 42, 2169-2179.
20. Tokarski, J. S.; Hopfinger, A. J. Constructing Protein Models for Ligand-Receptor Binding Thermodynamic Simulation: An Application to a Set of Peptidometic Renin Inhibitors. J. Chem. Inf. Comput. Sci. 1997, 37, 779-791.
21. Tokarski, J. S.; Hopfinger, A. J. Prediction of Ligand-Receptor Binding Thermodynamics by Free Energy Force Field (FEFF) 3D-QSAR Analysis: Application to a Set of Peptidometic Renin Inhibitors. J. Chem. Inf. Comput. Sci. 1997, 37, 792-811.
22. Hahn, M.; Rogers, D. Receptor Surface Models. 2. Application to Quantitative Structure-Activity Relationship Studies. J. Med. Chem. 1995, 38, 2091-2102.
23. Gokhale, V. M.; Kulkarni, V. M. Understanding the Antifungal Activity of Terbinafine Analogues using Quantitative Structure-Activity Relationship Models. Bioorg. Med. Chem. 2000, 8, 2487-2499.
24. Karki, R. G.; Kulkarni, V. M. Three-Dimensional Quantitative Relationship (3D-QSAR) Study of 3-Aryloxazolidin-2-one Antibacterials. Bioorg. Med. Chem. 2001, 9, 3153-3160.
25. Collins, L. A.; Franzblau, S. G. Microplate Alamar Blue Assay versus BACTEC 460 System for High Throughput Screening of Compounds Against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother. 1997, 41, 1004-1009.
26. Björkroth, J.-P.; Pakkanen, T. A.; Lindroos, J. Comparative Molecular Field Analysis of Some Clodronic Acid Esters. J. Med. Chem. 1991, 34, 2338-2343.
27. SYBYL Molecular Modeling System, Version 6.6; Tripos, Inc.: St. Louis, MO, 63144-2913.
28. Clark, M.; Cramer, R. D., III.; Van Opdenbosh, N. Validation of the General-Purpose Tripos 5.2 Force Field. J. Comput. Chem. 1989, 10, 982-1012.
29. MOPAC 6.0 is available from Quantum Chemistry Program Exchange, Indiana University.
30. Stewart, J. J. P. MOPAC: A Semiempirical Molecular Orbital Program. J. Comput.-Aided Mol. Des. 1990, 4, 1-103.
31. Kearsley, S. K.; Smith, G. M. An Alternative Method for the Alignment of Molecular Structures: Maximizing Electrostatic and Steric Overlap. Tetrahedron Comput. Methodol. 1990, 3, 615-633.
32. Dunn, W. J.; Wold, S.; Edelund, U.; Helberg, S. Multivariate Structure-Activity Relationships between Data from a Battery of Biological Tests and an Ensemble of Structure Descriptors: The PLS Methodol. Quant. Struct.-Act. Relat. 1984, 3, 131-137.
33. Cerius2 version 3.5 is available from Molecular Simulations Inc., 9685 Scranton Road, San Diego, CA, 92121.
34. Rappe, A. K.; Goddard, W. A., III. Charge Equilibration for Molecular Dynamics Simulations. J. Phys. Chem. 1991, 95, 3358-3363.
35. Hopfinger, A. J. A Quantitative Structure-Activity Relationship Investigation of Dihydrofolate Reductase Inhibition by Baker Triazines Based upon Molecular Shape Analysis. J. Am. Chem. Soc. 1980, 102, 7196-7206.
36. Cramer, R. D., III.; Bunce, J. D.; Patterson, D. E. Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies. Quant. Struct.-Act. Relat. 1988, 7, 18-25.
37. ClogP, version 1.0.0; Biobyte Corp.: 201 West, 4th St., Suite 204, Claremont, CA 91711.
38. FASA_P was calculated using QuaSAR_Descriptors Functionality in Molecular Operating Environment (MOE) 2001.01 available from Chemical Computing Group Inc., 1010 Sherbrooke Street West, Suite 910, Montreal, Canada H3A 2R7.